141 related articles for article (PubMed ID: 36060149)
1. Long Intergenic Nonprotein Coding RNA 00174 Aggravates Lung Squamous Cell Carcinoma Progression via MicroRNA-185-5p/Nuclear Factor IX axis.
Gu P; Lin L
Biomed Res Int; 2022; 2022():9490827. PubMed ID: 36060149
[TBL] [Abstract][Full Text] [Related]
2. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
[TBL] [Abstract][Full Text] [Related]
3. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
Li H; Zhao Q; Tang Z
Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
[TBL] [Abstract][Full Text] [Related]
5. Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis.
Wang S; Xia L; Zhang B; Zhang H; Lan F
Funct Integr Genomics; 2022 Aug; 22(4):643-653. PubMed ID: 35451652
[TBL] [Abstract][Full Text] [Related]
6. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
Zhang D; Hua M; Zhang N
Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302
[TBL] [Abstract][Full Text] [Related]
7. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
Lu Y
Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior
of Lung Squamous Cell Carcinoma H520 Cells].
Gou L; He Y; Qiu P; Huang B
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
Ma J; Qi G; Li L
Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway.
Zhao L; Song X; Guo Y; Ding N; Wang T; Huang L
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132359
[TBL] [Abstract][Full Text] [Related]
12. LINC00174 Suppresses Non-Small Cell Lung Cancer Progression by Up-Regulating LATS2 via Sponging miR-31-5p.
Cheng X; Sha M; Jiang W; Chen L; Song M
Cell J; 2022 Mar; 24(3):140-147. PubMed ID: 35451584
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2.
Zhang H; Luo Z; Tang J; Tian J; Xiao Y; Sun C; Wang T
Cell Cycle; 2022 Jan; 21(1):63-73. PubMed ID: 34985387
[TBL] [Abstract][Full Text] [Related]
14. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
[TBL] [Abstract][Full Text] [Related]
15. circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway.
Hu S; Cao P; Kong K; Han P; Yue J; Deng Y; Li F; Zhao B
Dis Markers; 2022; 2022():6329097. PubMed ID: 36016851
[TBL] [Abstract][Full Text] [Related]
16. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
[TBL] [Abstract][Full Text] [Related]
17. LINC00174 Facilitates Proliferation and Migration of Colorectal Cancer Cells via MiR-3127-5p/ E2F7 Axis.
Ma Y; Li Y; Tang Y; Tang N; Wang D; Li X
J Microbiol Biotechnol; 2021 Aug; 31(8):1098-1108. PubMed ID: 34226413
[TBL] [Abstract][Full Text] [Related]
18. Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
Ding J; Huang M; Huang B; Peng X; Wu G; Peng C; Zhang H; Mao C; Wu X
Environ Mol Mutagen; 2022 Aug; 63(7):351-361. PubMed ID: 36161731
[TBL] [Abstract][Full Text] [Related]
19. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00649 recruits TAF15 and enhances MAPK6 expression to promote the development of lung squamous cell carcinoma via activating MAPK signaling pathway.
Zhu H; Liu Q; Yang X; Ding C; Wang Q; Xiong Y
Cancer Gene Ther; 2022 Aug; 29(8-9):1285-1295. PubMed ID: 35228660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
